ArticleFrontiers in microbiology2026
Bactericidal and antibiofilm activity of lactic acid bacteria-derived cell free extracts against dairy-associated spoilage and pathogenic bacteria.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Chitosan-Based Composite Film Containing Cell-Free Supernatant ofGels (Basel, Switzerland) · 2026Article
- Lactic Acid Bacteria-Derived Postbiotics in Dairy Foods: Definitions, Functions and Regulatory Challenges.Microorganisms · 2026Review
- Exploring the Antibacterial and Antibiofilm Properties of Lactic Acid Bacteria Isolated From Sucuk and Dairy Products.Veterinary medicine and science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the antimicrobial and antibiofilm potential of 15 LAB strains using five types of LAB-derived preparations: cell-free supernatants (CFS), sonicated-inactivated cells (IC), their combination (ICS), and their neutralized variants (CFS N, ICS N) to identify the most effective strain-extract combinations for potential application as natural biocontrol agents in dairy systems. Antimicrobial activity was assessed through agar diffusion assays, growth and biofilm inhibition, and determination of minimum inhibitory (MIC) and bactericidal (MBC) concentrations. The extracts were further characterized by pH and organic acid profiles using high-performance liquid chromatography (HPLC), and their mechanisms of action were investigated through cellular leakage assays, time-kill kinetics, and scanning electron microscopy (SEM). Several LAB-derived extracts exhibited strong antagonistic and antibiofilm activity against both spoilage and pathogenic bacteria. Non-neutralized CFS and ICS showed pronounced bactericidal activity, confirming the central role of organic acids in microbial inhibition. Z-score ranking and leakage assays identified
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.